![Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions | Drug Metabolism & Disposition Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/styles/medium/public/highwire/dmd/49/12.cover-source.jpg?itok=3vtvG5Tj)
Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions | Drug Metabolism & Disposition
![Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses | Science Advances Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses | Science Advances](https://www.science.org/cms/10.1126/sciadv.abi6110/asset/9babf8d8-98d2-46cb-93e6-88532a01a253/assets/images/large/sciadv.abi6110-f2.jpg)
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses | Science Advances
![Antioxidants | Free Full-Text | Cannabidiol Protects Dopaminergic Neurons in Mesencephalic Cultures against the Complex I Inhibitor Rotenone Via Modulation of Heme Oxygenase Activity and Bilirubin Antioxidants | Free Full-Text | Cannabidiol Protects Dopaminergic Neurons in Mesencephalic Cultures against the Complex I Inhibitor Rotenone Via Modulation of Heme Oxygenase Activity and Bilirubin](https://pub.mdpi-res.com/antioxidants/antioxidants-09-00135/article_deploy/html/images/antioxidants-09-00135-ag.png?1583470534)
Antioxidants | Free Full-Text | Cannabidiol Protects Dopaminergic Neurons in Mesencephalic Cultures against the Complex I Inhibitor Rotenone Via Modulation of Heme Oxygenase Activity and Bilirubin
![Frontiers | Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies Frontiers | Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies](https://www.frontiersin.org/files/Articles/610484/fnbeh-14-610484-HTML/image_m/fnbeh-14-610484-g001.jpg)
Frontiers | Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies
![CBD is a competitive inhibitor at the ENT1 transporter in EOC-20 cells.... | Download Scientific Diagram CBD is a competitive inhibitor at the ENT1 transporter in EOC-20 cells.... | Download Scientific Diagram](https://www.researchgate.net/profile/Erica-Carrier/publication/7109024/figure/fig4/AS:667849869766667@1536239225945/CBD-is-a-competitive-inhibitor-at-the-ENT1-transporter-in-EOC-20-cells-A-Cells-were_Q320.jpg)
CBD is a competitive inhibitor at the ENT1 transporter in EOC-20 cells.... | Download Scientific Diagram
![Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease - ScienceDirect Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523420301306-fx1.jpg)
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease - ScienceDirect
CBD is a competitive inhibitor at the ENT1 transporter in EOC-20 cells.... | Download Scientific Diagram
![Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD) | Chemical Research in Toxicology Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD) | Chemical Research in Toxicology](https://pubs.acs.org/cms/10.1021/acs.chemrestox.2c00259/asset/images/large/tx2c00259_0005.jpeg)
Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD) | Chemical Research in Toxicology
![Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug–drug interactions involving canine cytochrome P‐450, UDP‐glucuronosyltransferase, and P‐glycoprotein - Court - Journal of Veterinary Pharmacology and ... Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug–drug interactions involving canine cytochrome P‐450, UDP‐glucuronosyltransferase, and P‐glycoprotein - Court - Journal of Veterinary Pharmacology and ...](https://onlinelibrary.wiley.com/cms/asset/4499fa31-c46b-43b6-bde9-597a98e31bf3/jvp13403-fig-0005-m.jpg)
Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug–drug interactions involving canine cytochrome P‐450, UDP‐glucuronosyltransferase, and P‐glycoprotein - Court - Journal of Veterinary Pharmacology and ...
![Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease - ScienceDirect Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523421005845-ga1.jpg)
Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease - ScienceDirect
Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two” | Journal of Natural Products
![Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression | PNAS Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression | PNAS](https://www.pnas.org/cms/10.1073/pnas.0511232103/asset/71a4828c-c7a2-45fd-80f8-e30ea87cbb8d/assets/graphic/zpq0210622620002.jpeg)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression | PNAS
![Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations | Scientific Reports Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-94212-6/MediaObjects/41598_2021_94212_Fig1_HTML.png)
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations | Scientific Reports
![Frontiers | Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities Frontiers | Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities](https://www.frontiersin.org/files/Articles/781852/fnbeh-15-781852-HTML/image_m/fnbeh-15-781852-g001.jpg)
Frontiers | Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities
![Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models | Drug Metabolism & Disposition Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/50/7/968/F1.large.jpg)
Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models | Drug Metabolism & Disposition
![Antioxidants | Free Full-Text | Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions Antioxidants | Free Full-Text | Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions](https://pub.mdpi-res.com/antioxidants/antioxidants-11-02049/article_deploy/html/images/antioxidants-11-02049-g001.png?1666773175)
Antioxidants | Free Full-Text | Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
![Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression | PNAS Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression | PNAS](https://www.pnas.org/cms/10.1073/pnas.0511232103/asset/6d644c5f-14e8-4c38-a2a1-d31a4eea83d5/assets/graphic/zpq0210622620001.jpeg)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression | PNAS
![Frontiers | Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions Frontiers | Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions](https://www.frontiersin.org/files/Articles/505470/fnbeh-14-00032-HTML/image_m/fnbeh-14-00032-g001.jpg)
Frontiers | Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions
![Biomolecules | Free Full-Text | Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders Biomolecules | Free Full-Text | Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders](https://pub.mdpi-res.com/biomolecules/biomolecules-10-01575/article_deploy/html/images/biomolecules-10-01575-g001.png?1605860981)